Ask Reporter 24Global Synthetic Biology Workstation Market 2018-2022 – Increasing …Business Wire (press release)One trend in the market is growing number of startups in synthetic biology. With the increasing number of venture capitalists willing to f… Continue reading
FierceBiotech |
Gilead/Kite team up with Pfizer for CAR–T-mAb combination
FierceBiotech Yescarta (axicabtagene ciloleucel), approved by the FDA last year in the first wave of new CAR–T cell therapies, will be teamed up with Pfizer’s experimental humanized 4-1BB agonist utomilumab in patients with refractory large B-cell lymphoma. The … Kite Announces Clinical Collaboration to Evaluate Investigational Combination of Yescarta™ (Axicabtagene Ciloleucel …Business Wire (press release) |
Life Sciences Intellectual Property Review |
Mixed views on Broad’s fate after EPO revokes CRISPR patent
Life Sciences Intellectual Property Review Daniel Lim, senior associate at Allen & Overy, attended the hearing at the EPO. He has since told LSIPR that while some of Broad’s other opposed CRISPR patents will be vulnerable to revocation based on lack of priority, the institute does have other … |